Filing Flows

Filing Flows › Marimed (MRMD) › Q1 2026 › vs Q1 2025

Marimed (MRMD) Q1 2026 vs Q1 2025 (year over year)

Marimed's revenue rose $1.6M (+4%) from $37.9M in Q1 2025 to $39.5M in Q1 2026. The biggest changes: Product sales - retail +$997K (+5%); Product sales - wholesale +$731K (+4%); Other revenue −$153K (-39%).

Marimed, Q1 2026: revenue $39.5M (+4% year over year), operating margin 0.3%, net loss $3.8M, operating cash flow $949K. The chart draws each line against Q1 2025, the increases inside each band.

Marimed: what changed, Q1 2026 vs Q1 2025Marimed: what changed, Q1 2026 vs Q1 2025Working capital & other−$2.2MOperating cash sources−$2.1MNet loss−$1.7MNet loss absorbed−$1.7MCost of revenue$1.4MOther operating costs−$1.3MProduct sales - retail$997KProduct sales - wholesale$731KGeneral & admin$637KOperating costs$540K

Margins

Q1 2026Q1 2025Change
Free cash flow margin1.5%2.7%-1.3 pts

Every line

LineQ1 2026Q1 2025Change%
Product sales - retail$21.7M$20.7M$997K+5%
Product sales - wholesale$17.5M$16.8M$731K+4%
Other revenue$237K$390K−$153K-39%
Revenue$39.5M$37.9M$1.6M+4%
Net loss$3.8M$5.5M−$1.7M-31%
Costs & expenses$43.2M$43.4M−$137K-0.3%
Operating costs$39.4M$38.8M$540K+1%
Interest & other, net$1.2M$1.7M−$497K-29%
Income tax$2.7M$2.8M−$180K-6%
Cost of revenue$24.2M$22.8M$1.4M+6%
Sales & marketing$765K$908K−$143K-16%
General & admin$6.9M$6.2M$637K+10%
Other operating costs$7.5M$8.8M−$1.3M-15%
Operating cash sources$4.7M$6.8M−$2.1M-30%
Depreciation & amortization$2.2M$1.8M$346K+19%
Share-based compensation$325K$547K−$222K-41%
Working capital & other$2.2M$4.4M−$2.2M-49%
Net loss absorbed$3.8M$5.5M−$1.7M-31%
Operating cash flow$949K$1.3M−$344K-27%
Free cash flow (OCF − capex)$576K$1.0M−$451K-44%
Capital expenditures$373K$266K$107K+40%

Questions

How much did Marimed's revenue grow year over year in Q1 2026?

Marimed's revenue rose $1.6M (+4%) from $37.9M in Q1 2025 to $39.5M in Q1 2026.

What drove Marimed's revenue change in Q1 2026?

Product sales - retail +$997K (+5%); Product sales - wholesale +$731K (+4%); Other revenue −$153K (-39%).

Q1 2026 results → · Compare in the interactive Sankey →